To define the signaling pathways that mediate Dragon action on colorectal cancer cell proliferation, we analyzed Smad1/5/8, AKT, Erk1/2 and p38 phosphorylation levels in the stable Dragon knockdown CT26.WT and CMT93 mouse cells. Here, RGMB is linked to colorectal cancer.